Subscreva a nossa newsletter para se manter atualizado
Clique aqui
  • BLS

Guia de segurança: Amianto

BLS Safety Guide: Asbestos


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

In the five-year period 2016-2020, an average of about 1,500 workers per year were recognised as having an asbestos-related disease. In the same years, around 50% of workers who contracted asbestos-related diseases suffered a permanent impairment of no more than 25%, while 37% of technopaths died as a result of the occupational disease. Specifically in 2016, the proportion of workers with an impairment of no more than 25 per cent remained almost unchanged, but those with a fatal outcome rose to 43 per cent.

The use of asbestos was banned in Italy in 1992 with Law No. 257, which set the terms and procedures for the cessation of all activities involving the processing and extraction of this mineral. After this date, the only permitted work activities involving exposure to asbestos are its clearance, removal and disposal.

The IARC (International Agency for Research on Cancer) has classified asbestos as a human carcinogen (Group 1).

The danger of asbestos derives from the degree of fibre freedom, i.e. the ability of asbestos-containing materials to release potentially inhalable fibres into the air. Since asbestos is a friable and fibrous material, it is easy for very small particles to be released into the air as a result of any type of stress (processing and handling, vibrations, infiltration of humidity), which, once inhaled, are capable of being deposited in the pulmonary alveoli, bronchi and pleura, causing irreversible tissue damage and the onset of pulmonary diseases. Moreover, as there is no risk threshold below which the concentration of asbestos fibres in the air is not dangerous, it follows that the inhalation of even a single fibre can cause fatal pathologies; clearly, prolonged exposure over time or to high quantities will exponentially increase the likelihood of contracting such pathologies.

The European Commission has recently approved an exposure limit value (or TLV) 10 times lower than the previous one (0.1 fibres/cm3), i.e. 0.01 fibres/cm3, for an 8-hour exposure reference. The harmful effects that occur following the inhalation of asbestos particles are derived from pathogenic mechanisms of an irritative, degenerative and carcinogenic nature and can lead to the onset of various diseases.

The pathologies resulting from breathing in asbestos fibres are all characterised by a long interval between the start of exposure and the appearance of the first symptoms of the disease: this interval, termed 'latency time', can generally last up to decades.

From these pathologies related to exposure to asbestos derives the importance of worker protection, which must be on several fronts: the worker must be equipped with personal respiratory protective equipment with an operational protection factor that ensures that the filtered air inside the PPE is no more than 1/10 of the limit value. The use of PPE must also be interspersed with rest periods appropriate to the physical effort required by the work, and the employer must carry out periodic measurements of the concentration of fibres in the air, reporting the results in the DVR (Risk Assessment Document).

 

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Artigos relacionados

janeiro 1, 2021 Partnership Assosistema e Fondazione Politecnico

BLS apre il 2021 entrando a far parte di Fondazione Politecnico di Milano e aderendo ad ASSOSISTEMA Confindustria (nella Sezione “Sicurezza sul lavoro/Safety”): “Siamo orgogliosi di partecipare a due delle più importanti associazioni di categoria che ci supporteranno nel nostro percorso e ci permetteranno di essere sempre più posizionati e innestati nel territorio, per proseguire […]

Link
dezembro 21, 2022 2022 BLS & Yamaha Motor Racing partnership

Scopri tutti i momenti più importanti Il 2022 ha sancito l'inizio della partnership tra BLS Group e il team di Monster Energy Yamaha MotoGP. Celebriamo l'anno passato condividendo tutti i momenti salienti che hanno scandito la partnership condivisa tra due campioni in sicurezza: BLS Group e il team Monster Energy Yamaha MotoGP. Siamo orgogliosi di […]

Link
março 26, 2024 Instruções de vestimenta | Série BLS 5000

Istruzioni d'indossamento | Serie BLS 5000 Indossare un DPI nel modo corretto è fondamentale per trarne massima efficacia e migliori performance di prodotto. La protezione respiratoria individuale ha lo scopo di difendere chi la utilizza da sostanze nocive o agenti patogeni presenti nell'aria. Prima di utilizzarla, è fondamentale ricevere un'adeguata formazione sul corretto metodo di […]

Link
Assine a newsletter
Receba atualizações sobre nossos eventos, notícias do catálogo e iniciativas futuras.
Inscreva-se

Contate-nos

Escreva-nos sobre todas as suas necessidades e entraremos em contato com você em até 48 horas.
Solicitar informações

BLS S.R.L.
Empresa com um único membro
via dei Giovi, 41 - 20032 Cormano (MI) - Itália
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Política de privacidade - Política de cookies

Sede legal
via dei Giovi, 41 - 20032 Cormano (MI) - Itália
Capital social: Euro 600.000,00 i.v.
C.C.I.A. - R.E.A.: MI 1186898
Número de IVA: IT12296780153
Código fiscal e entrada no Registro de Empresas de Milão: 07822320151

BLS IBÉRIA / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Espanha
BLS NOROESTE / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - Países Baixos
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 São Paulo - SP - Brasil
BLS ALEMANHA / Dünner Straße 249 D-41066 Mönchengladbach - Alemanha
BLS FRANÇA / 18 Porte du Grand Lyon 01700 Neyron - França

cruzadomenuchevron-downcírculo cruzado